IDO1 and neoplasm: Additionally, interdigitating DCs and tumor cells overexpress indoleamine 2,3-dioxygenase (IDO) that is known to prevent immune-mediated rejection of the tumor cells, block CD8+ T cells proliferation, and favor CD4+ apoptosis [74,75].